Table 3.
Final Diagnoses (n = 1459).
| Diagnoses | Frequency (N) | Percent (%) |
|---|---|---|
| COVID-19 pneumonia without known comorbidities | 550 | 37.6 |
| COVID-19 pneumonia with comorbidities | 699 | 48 |
| Hypertension | 214 | 14.6 |
| Kidney disease | 115 | 7.9 |
| Hypertension with Diabetes mellitus | 100 | 6.9 |
| Chronic obstructive pulmonary disease | 62 | 4.2 |
| Diabetic ketoacidosis | 57 | 4 |
| Thyroid disorder | 53 | 3.6 |
| Carcinoma | 35 | 2.6 |
| Coronary Heart Disease | 28 | 1.8 |
| Chronic liver disease | 10 | 0.7 |
| Rheumatoid arthritis | 7 | 0.5 |
| Other Comorbiditiesa | 18 | 1.2 |
| COVID-19 pneumonia with complications | ||
| COVID-19 pneumonia-induced ARDS and/or sepsis | 163 | 11.2 |
| COVID-19 pneumonia with Atrial fibrillation | 14 | 1.0 |
| Other diagnosis | ||
| COVID-19 pneumonia with MI with HTN | 22 | 1.5 |
| COVID-19 pneumonia with Ischemic Stroke with HTN | 6 | 0.4 |
| RTA with SAH with RT-PCR positive for COVID-19 | 5 | 0.3 |
a
Other Comorbidities include: Pulmonary Tuberculosis, Hepatitis C, Crohn's disease, Idiopathic Thrombocytopenic Purpura, Scrub Typhus, Schizophrenia, Cushing's syndrome, Leprosy, Organophosphorus Poisoning.
ARDS, Acute Respiratory Distress Syndrome; HTN, Hypertension; MI, Myocardial Infarction; RTA, Road Traffic Accident; RT-PCR, Reverse Transcriptase Polymerase Chain Reaction, SAH, Subarachnoid Hemorrhage.